Skip to main content
DNA Labs India

IRFA-MUM1 Test

DNA Labs India | ISO 9001:2015 Certified

IRFA-MUM1 Test

IRFA-MUM1 Test test available at DNA Labs India for ₹9,000. Uses FISH on Tumor tissue samples. Results in 7-8 days. Free home collection in 300+ cities across India.

OncologyAdults🏠 Home Collection

✍️ Written By

🩺 Medically Reviewed By

Dr Pasupathy Arumugam

Dr Pasupathy Arumugam

Consultant Pathologist · Reg: 21521

Last reviewed: September 7, 2026

Overview

The purpose of the IRFA-MUM1 test is to detect genetic mutations associated with an increased risk of hereditary cancers. By identifying these mutations, individuals and healthcare providers can implement targeted screening, prevention strategies, and early treatment options to manage cancer risk effectively.

Test Code
3060
Price
₹9,000
Sample Type
Tumor tissue
Result Time
7-8 days
Fasting Required
No
Method
FISH
Step 1

Sample Collection

A doctor's prescription is required for the IRFA-MUM1 test, except in cases of surgery, pregnancy, or travel abroad. Ensure proper documentation and consultation with a healthcare provider.

Method: Biopsy or surgical specimen collection

Step 2

Laboratory Analysis

Sample collection involves obtaining a tumor tissue specimen, typically via biopsy or surgical procedure, under sterile conditions.

Step 3

Report Delivery

The sample is processed in the laboratory using FISH technology. Results are analyzed and compiled into a detailed report.

Timeline: 7-8 days

Patient Instructions

1
Before the Test:Obtain a doctor's prescription and ensure proper sample collection arrangements.
2
During the Test:Tumor tissue sample is collected and sent to the laboratory for FISH analysis.
3
After the Test:Results are available in 7-8 days; review with a healthcare provider for interpretation.

About This Test

Who Should Get This Test

The purpose of the IRFA-MUM1 test is to detect genetic mutations associated with an increased risk of hereditary cancers. By identifying these mutations, individuals and healthcare providers can implement targeted screening, prevention strategies, and early treatment options to manage cancer risk effectively.

How to Prepare

  • Obtain a valid doctor's prescription
  • Ensure tumor tissue sample is collected in a sterile container
  • Label the sample with patient details and test information
  • Transport the sample to the laboratory under appropriate conditions

Doctor's Notes

Reviewed by — MBBS, MD (Pathology) · Reg. No. 21521

"Genetic testing like IRFA-MUM1 is crucial for individuals with a family history of hereditary cancers, enabling early detection and personalized prevention strategies."

Last medically reviewed: September 7, 2026

Test Parameters & Specifications

Sample TypeTumor tissue
Collection MethodBiopsy or surgical specimen collection

Sample Stability

Paraffin-embedded tissue blocks are stable at room temperature for extended periods
Consult laboratory for specific stability guidelines
Sample Rejection Criteria:
  • Insufficient or degraded tumor tissue
  • Missing or incorrect patient information
  • Lack of doctor's prescription where required

Understanding Your Results

The IRFA-MUM1 test results indicate the presence or absence of specific genetic mutations. A positive result suggests an increased risk of hereditary cancers, while a negative result indicates no detected mutations. Results should be reviewed by a healthcare professional for personalized guidance.
📊

Positive

Mutation detected; increased risk of breast, ovarian, prostate, pancreatic cancers, or melanoma. Recommend genetic counseling and enhanced screening.

Action: Consult an oncologist for risk management and prevention strategies.

📊

Negative

No mutation detected; risk may be similar to general population. Continue routine screening as advised.

Action: Discuss with healthcare provider for ongoing monitoring.

⚠️ When to Consult a Doctor:

Consult a doctor if you have a family history of hereditary cancers, experience symptoms like unexplained lumps or persistent pain, or receive a positive test result for further evaluation and management.

Limitations

  • ⚠Test only detects specific IRFA-MUM1 mutations; other genetic variants may not be identified
  • ⚠Results should be interpreted in conjunction with clinical history and family pedigree
  • ⚠Not a diagnostic test for cancer but a risk assessment tool

Risks & Considerations

  • ●Minimal risks associated with biopsy or surgical sample collection, such as infection or bleeding
  • ●Psychological impact of genetic risk information

Interfering Factors

  • ●Degraded or insufficient tumor tissue sample
  • ●Contamination during sample collection or processing

Frequently Asked Questions

What is the IRFA-MUM1 test?
The IRFA-MUM1 test is a genetic test that identifies specific mutations increasing the risk of hereditary cancers like breast, ovarian, prostate, pancreatic, and melanoma.
Who should consider the IRFA-MUM1 test?
Individuals with a family history of hereditary cancers, personal history of cancer, or symptoms suggestive of genetic predisposition should consider this test.
What is the cost of the IRFA-MUM1 test at DNA Labs India?
The cost is INR 9000, which includes all laboratory fees and a detailed report.
How is the IRFA-MUM1 test performed?
It is a blood or tissue test using FISH technology to analyze DNA for specific genetic mutations.
Is home sample collection available for the IRFA-MUM1 test?
Yes, DNA Labs India offers free home sample collection across India for online bookings.
How long does it take to get IRFA-MUM1 test results?
Results are typically available within 7-8 days.
Do I need a doctor's prescription for the IRFA-MUM1 test?
Yes, a doctor's prescription is required, except in cases of surgery, pregnancy, or travel abroad.
What does a positive IRFA-MUM1 test result mean?
A positive result indicates the presence of genetic mutations linked to increased cancer risk, requiring further consultation with an oncologist.
What does a negative IRFA-MUM1 test result mean?
A negative result means no specific mutations were detected, but routine screening should continue as advised.
Is the IRFA-MUM1 test covered by insurance?
Coverage depends on your insurance plan; check with your provider for details.
What sample type is required for the IRFA-MUM1 test?
The test requires tumor tissue, such as paraffin-embedded tissue blocks.
Can the IRFA-MUM1 test diagnose cancer?
No, it is a risk assessment tool, not a diagnostic test for cancer. Results should be interpreted by healthcare professionals.
Worried about the process? Our certified phlebotomists collect thousands of samples every month across India. The process takes under 5 minutes and is virtually painless. Questions? Message us on WhatsApp — we're here 7 days a week.

Related Tests

B-Cell Rearrangement Detection Test

₹22,000

Acute Lymphoblastic Leukemia (ALL) Cytogenetics Panel Test

₹20,000

Epstein-Barr Virus Early RNA (EBER-ISH) In-Situ-Hybridization Test

₹6,000

OncoPro NCCN Lung Cancer Panel with PD-L1 Test

₹140,400

Acute Myeloid Leukemia (AML) Cytogenetics Panel Test

₹23,000

AML ETO t(8;21) Gene Rearrangement PCR Qualitative Test

₹6,000
For Hospitals & Clinics

Reference Laboratory Services

We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.

LIMS Integration

Your Data Privacy

Your medical data is protected under Indian law.

✓ Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.

✓ DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.

Book Your Test

Enter your details and we'll connect you within 15 minutes.

🧬

Quick Connect

Enter your mobile number and we’ll connect you with the team.

+91

✅ Connecting you now...

🔒 Your number is used to respond to this request.